Close Menu

Losing the Award

Three grants issued by the California Institute of Regenerative Medicine have been terminated, reports The Scientist. In reviewing the recipients' first year progress reports, CIRM identified underperforming project. The reviewers then contacted the PIs to learn what the difficulties were and then if the grantees' follow-up report didn't show improvement, the grant was terminated. "Termination is a last option," CIRM's Don Gibbons says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.